Kimmel Paul L, Cohen Scott D, Weisbord Steven D
Division of Renal Diseases and Hypertension, Department of Medicine, GWU Medical Center, George Washington University, 2150 Pennsylvania Avenue NW, Washington, DC 20037, USA.
J Nephrol. 2008 Mar-Apr;21 Suppl 13:S54-8.
The quality of life (QoL) of end stage renal disease (ESRD) patients is a frequently overlooked yet critical consideration when evaluating the overall medical care of patients. There are a variety of measures used to assess the QoL of ESRD patients. Some of the more frequently used tools include the single-question QoL questionnaire, the 36 Item Short Form Health Survey (SF-36), and the Kidney Disease Quality of Life (KDQoL) questionnaire. The best intervention to improve the QoL of ESRD patients is renal transplantation. The role of erythropoietin and intensification of dialysis dose in improving patients' QoL is undergoing review. We have previously shown relationships between patients' perception of quality of life and depressive affect, perception of burden of illness (IEQ), social support (MSP), pain and sleep disturbances. Further studies should focus on interventions that modify patients' perceptions of these psychosocial parameters with the goal of improving their QoL. Treatment of depression, pain and sleep disorders holds particular promise in this regard.
在评估患者的整体医疗护理时,终末期肾病(ESRD)患者的生活质量(QoL)是一个经常被忽视但至关重要的考量因素。有多种措施用于评估ESRD患者的生活质量。一些较为常用的工具包括单问题生活质量问卷、36项简短健康调查(SF-36)以及肾病生活质量(KDQoL)问卷。改善ESRD患者生活质量的最佳干预措施是肾移植。促红细胞生成素和强化透析剂量在改善患者生活质量方面的作用正在接受审查。我们之前已经表明,患者对生活质量的认知与抑郁情绪、疾病负担认知(IEQ)、社会支持(MSP)、疼痛和睡眠障碍之间存在关联。进一步的研究应聚焦于改变患者对这些心理社会参数认知的干预措施,目标是改善他们的生活质量。在这方面,治疗抑郁症、疼痛和睡眠障碍尤其具有前景。